These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 17000764)

  • 1. Dimerization of the I kappa B kinase-binding domain of NEMO is required for tumor necrosis factor alpha-induced NF-kappa B activity.
    Marienfeld RB; Palkowitsch L; Ghosh S
    Mol Cell Biol; 2006 Dec; 26(24):9209-19. PubMed ID: 17000764
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phosphorylation of serine 68 in the IkappaB kinase (IKK)-binding domain of NEMO interferes with the structure of the IKK complex and tumor necrosis factor-alpha-induced NF-kappaB activity.
    Palkowitsch L; Leidner J; Ghosh S; Marienfeld RB
    J Biol Chem; 2008 Jan; 283(1):76-86. PubMed ID: 17977820
    [TBL] [Abstract][Full Text] [Related]  

  • 3. NEMO-binding domains of both IKKalpha and IKKbeta regulate IkappaB kinase complex assembly and classical NF-kappaB activation.
    Solt LA; Madge LA; May MJ
    J Biol Chem; 2009 Oct; 284(40):27596-608. PubMed ID: 19666475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dimer of arfaptin 2 regulates NF-κB signaling by interacting with IKKβ/NEMO and inhibiting IKKβ kinase activity.
    You DJ; Park CR; Furlong M; Koo O; Lee C; Ahn C; Seong JY; Hwang JI
    Cell Signal; 2015 Nov; 27(11):2173-81. PubMed ID: 26296658
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Regulation and function of IKK and IKK-related kinases.
    Häcker H; Karin M
    Sci STKE; 2006 Oct; 2006(357):re13. PubMed ID: 17047224
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sensing of Lys 63-linked polyubiquitination by NEMO is a key event in NF-kappaB activation [corrected].
    Wu CJ; Conze DB; Li T; Srinivasula SM; Ashwell JD
    Nat Cell Biol; 2006 Apr; 8(4):398-406. PubMed ID: 16547522
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Disulfide-mediated stabilization of the IκB kinase binding domain of NF-κB essential modulator (NEMO).
    Zhou L; Yeo AT; Ballarano C; Weber U; Allen KN; Gilmore TD; Whitty A
    Biochemistry; 2014 Dec; 53(50):7929-44. PubMed ID: 25400026
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interleukin-1-induced NF-kappaB activation is NEMO-dependent but does not require IKKbeta.
    Solt LA; Madge LA; Orange JS; May MJ
    J Biol Chem; 2007 Mar; 282(12):8724-33. PubMed ID: 17244613
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Novel non-peptide small molecules preventing IKKβ/NEMO association inhibit NF-κB activation in LPS-stimulated J774 macrophages.
    De Falco F; Di Giovanni C; Cerchia C; De Stefano D; Capuozzo A; Irace C; Iuvone T; Santamaria R; Carnuccio R; Lavecchia A
    Biochem Pharmacol; 2016 Mar; 104():83-94. PubMed ID: 26776306
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mutation of nonessential cysteines shows that the NF-κB essential modulator forms a constitutive noncovalent dimer that binds IκB kinase-β with high affinity.
    Cote SM; Gilmore TD; Shaffer R; Weber U; Bollam R; Golden MS; Glover K; Herscovitch M; Ennis T; Allen KN; Whitty A
    Biochemistry; 2013 Dec; 52(51):9141-54. PubMed ID: 24266532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Direct inhibition of NF-κB activation by peptide targeting the NOA ubiquitin binding domain of NEMO.
    Chiaravalli J; Fontan E; Fsihi H; Coic YM; Baleux F; Véron M; Agou F
    Biochem Pharmacol; 2011 Nov; 82(9):1163-74. PubMed ID: 21803029
    [TBL] [Abstract][Full Text] [Related]  

  • 12. NEMO differentially regulates TCR and TNF-α induced NF-κB pathways and has an inhibitory role in TCR-induced NF-κB activation.
    Wang K; Diao LH; Gong Y; Liu X; Li Y
    Cell Signal; 2012 Aug; 24(8):1556-64. PubMed ID: 22513115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The IkappaB kinase (IKK) inhibitor, NEMO-binding domain peptide, blocks osteoclastogenesis and bone erosion in inflammatory arthritis.
    Dai S; Hirayama T; Abbas S; Abu-Amer Y
    J Biol Chem; 2004 Sep; 279(36):37219-22. PubMed ID: 15252035
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective inhibition of NF-kappaB activation by a peptide that blocks the interaction of NEMO with the IkappaB kinase complex.
    May MJ; D'Acquisto F; Madge LA; Glöckner J; Pober JS; Ghosh S
    Science; 2000 Sep; 289(5484):1550-4. PubMed ID: 10968790
    [TBL] [Abstract][Full Text] [Related]  

  • 15. ABIN-1 binds to NEMO/IKKgamma and co-operates with A20 in inhibiting NF-kappaB.
    Mauro C; Pacifico F; Lavorgna A; Mellone S; Iannetti A; Acquaviva R; Formisano S; Vito P; Leonardi A
    J Biol Chem; 2006 Jul; 281(27):18482-8. PubMed ID: 16684768
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NEMO binding domain of IKK-2 encompasses amino acids 735-745.
    Strnad J; McDonnell PA; Riexinger DJ; Mapelli C; Cheng L; Gray H; Ryseck RP; Burke JR
    J Mol Recognit; 2006; 19(3):227-33. PubMed ID: 16583354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DARPin-assisted crystallography of the CC2-LZ domain of NEMO reveals a coupling between dimerization and ubiquitin binding.
    Grubisha O; Kaminska M; Duquerroy S; Fontan E; Cordier F; Haouz A; Raynal B; Chiaravalli J; Delepierre M; Israël A; Véron M; Agou F
    J Mol Biol; 2010 Jan; 395(1):89-104. PubMed ID: 19854204
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Structure of a NEMO/IKK-associating domain reveals architecture of the interaction site.
    Rushe M; Silvian L; Bixler S; Chen LL; Cheung A; Bowes S; Cuervo H; Berkowitz S; Zheng T; Guckian K; Pellegrini M; Lugovskoy A
    Structure; 2008 May; 16(5):798-808. PubMed ID: 18462684
    [TBL] [Abstract][Full Text] [Related]  

  • 19. TNFalpha- and IKKbeta-mediated TANK/I-TRAF phosphorylation: implications for interaction with NEMO/IKKgamma and NF-kappaB activation.
    Bonif M; Meuwis MA; Close P; Benoit V; Heyninck K; Chapelle JP; Bours V; Merville MP; Piette J; Beyaert R; Chariot A
    Biochem J; 2006 Mar; 394(Pt 3):593-603. PubMed ID: 16336209
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A point mutation in NEMO associated with anhidrotic ectodermal dysplasia with immunodeficiency pathology results in destabilization of the oligomer and reduces lipopolysaccharide- and tumor necrosis factor-mediated NF-kappa B activation.
    Vinolo E; Sebban H; Chaffotte A; Israël A; Courtois G; Véron M; Agou F
    J Biol Chem; 2006 Mar; 281(10):6334-48. PubMed ID: 16379012
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.